Gts Securities LLC Tg Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $789,012 - $1.29 Million
60,600 Added 39.07%
215,700 $3.28 Million
Q4 2023

Feb 14, 2024
BUY
$6.68 - $18.81 $222,444 - $626,373
33,300 Added 27.34%
155,100 $2.65 Million
Q3 2023

Nov 15, 2023
BUY
$8.36 - $26.5 $1.02 Million - $3.23 Million
121,800 New
121,800 $1.02 Million

Others Institutions Holding TGTX

# of Institutions
269
Shares Held
87.7M
Call Options Held
2.72M
Put Options Held
1.74M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $2.66B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email